▶ 調査レポート

酔い止め薬の世界市場 2020年:企業別・地域別・種類別・用途別市場予測

• 英文タイトル:Global Seasickness Medicine Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが調査・発行した産業分析レポートです。酔い止め薬の世界市場 2020年:企業別・地域別・種類別・用途別市場予測 / Global Seasickness Medicine Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025 / D0804-11680資料のイメージです。• レポートコード:D0804-11680
• 出版社/出版日:GlobalInfoResearch / 2020年8月3日
※2025年版があります。お問い合わせください。

• レポート形態:英文、PDF、101ページ
• 納品方法:Eメール
• 産業分類:医薬品・治療
• 販売価格(消費税別)
  Single User¥487,200 (USD3,480)▷ お問い合わせ
  Multi User¥730,800 (USD5,220)▷ お問い合わせ
  Corporate User¥974,400 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、酔い止め薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。酔い止め薬の種類別市場規模(抗コリン薬、抗ヒスタミン剤、その他)、用途別市場規模(大人、子供)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・メーカー情報(販売量、市場シェア、製品概要、SWOT分析):GlaxoSmithKline、Myungmoon Pharm、Baxter International、Prestige Brands、Pfizer、WellSpring Pharmaceutical Corporation、Sandoz、Mylan、Caleb Pharmaceuticals
・地域別グローバル市場分析 2015年-2020年
・酔い止め薬の北米市場(アメリカ、カナダ、メキシコ)
・酔い止め薬のヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・酔い止め薬のアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・酔い止め薬の南米市場(ブラジル、アルゼンチン)
・酔い止め薬の中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:抗コリン薬、抗ヒスタミン剤、その他
・用途別分析:大人、子供
・地域別市場規模予測 2021年-2025年
・販売チャネル、流通業者、代理店
・調査の結果・結論

Market Overview
The Seasickness Medicine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The most likely (base case) scenario is that the global Seasickness Medicine sales will be xx in 2020 from Seasickness Medicine million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Seasickness Medicine market size is expected to grow at xx% or more annually for the next five years.

This report also researches and evaluates the impact of Covid-19 outbreak on the Seasickness Medicine industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Seasickness Medicine and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).

Market segmentation
Seasickness Medicine market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Seasickness Medicine market has been segmented into
Anticholinergic
Antihistamines
Others

By Application, Seasickness Medicine has been segmented into:
Adults
Children

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Seasickness Medicine market presented in the report. This section sheds light on the sales growth of different regional and country-level Seasickness Medicine markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Seasickness Medicine market.

The report offers in-depth assessment of the growth and other aspects of the Seasickness Medicine market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Seasickness Medicine Market Share Analysis
Seasickness Medicine competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Seasickness Medicine sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Seasickness Medicine sales, revenue and market share for each player covered in this report.

The major players covered in Seasickness Medicine are:
GlaxoSmithKline
Myungmoon Pharm
Baxter International
Prestige Brands
Pfizer
WellSpring Pharmaceutical Corporation
Sandoz
Mylan
Caleb Pharmaceuticals

Among other players domestic and global, Seasickness Medicine market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Seasickness Medicine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Seasickness Medicine, with price, sales, revenue and global market share of Seasickness Medicine in 2018 and 2019.
Chapter 3, the Seasickness Medicine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Seasickness Medicine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Seasickness Medicine market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Seasickness Medicine sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

1 Market Overview
1.1 Seasickness Medicine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Seasickness Medicine Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Anticholinergic
1.2.3 Antihistamines
1.2.4 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Seasickness Medicine Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Adults
1.3.3 Children
1.4 Overview of Global Seasickness Medicine Market
1.4.1 Global Seasickness Medicine Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
1.6 COVID-19 Outbreak: Seasickness Medicine Industry Impact
1.6.1 COVID-19 Potential Implications for the Seasickness Medicine
1.6.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Seasickness Medicine
1.6.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.6.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.6.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.6.2 Opportunity Analysis in Covid-19 Crisis
1.6.3 Market Risk and Restraints
1.6.4 Market Driving Force
2 Manufacturers Profiles
2.1 GlaxoSmithKline
2.1.1 GlaxoSmithKline Details
2.1.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 GlaxoSmithKline SWOT Analysis
2.1.4 GlaxoSmithKline Product and Services
2.1.5 GlaxoSmithKline Seasickness Medicine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Myungmoon Pharm
2.2.1 Myungmoon Pharm Details
2.2.2 Myungmoon Pharm Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Myungmoon Pharm SWOT Analysis
2.2.4 Myungmoon Pharm Product and Services
2.2.5 Myungmoon Pharm Seasickness Medicine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Baxter International
2.3.1 Baxter International Details
2.3.2 Baxter International Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Baxter International SWOT Analysis
2.3.4 Baxter International Product and Services
2.3.5 Baxter International Seasickness Medicine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Prestige Brands
2.4.1 Prestige Brands Details
2.4.2 Prestige Brands Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Prestige Brands SWOT Analysis
2.4.4 Prestige Brands Product and Services
2.4.5 Prestige Brands Seasickness Medicine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Pfizer
2.5.1 Pfizer Details
2.5.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Pfizer SWOT Analysis
2.5.4 Pfizer Product and Services
2.5.5 Pfizer Seasickness Medicine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 WellSpring Pharmaceutical Corporation
2.6.1 WellSpring Pharmaceutical Corporation Details
2.6.2 WellSpring Pharmaceutical Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 WellSpring Pharmaceutical Corporation SWOT Analysis
2.6.4 WellSpring Pharmaceutical Corporation Product and Services
2.6.5 WellSpring Pharmaceutical Corporation Seasickness Medicine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Sandoz
2.7.1 Sandoz Details
2.7.2 Sandoz Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Sandoz SWOT Analysis
2.7.4 Sandoz Product and Services
2.7.5 Sandoz Seasickness Medicine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Mylan
2.8.1 Mylan Details
2.8.2 Mylan Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Mylan SWOT Analysis
2.8.4 Mylan Product and Services
2.8.5 Mylan Seasickness Medicine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Caleb Pharmaceuticals
2.9.1 Caleb Pharmaceuticals Details
2.9.2 Caleb Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Caleb Pharmaceuticals SWOT Analysis
2.9.4 Caleb Pharmaceuticals Product and Services
2.9.5 Caleb Pharmaceuticals Seasickness Medicine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Seasickness Medicine Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Seasickness Medicine Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Seasickness Medicine Manufacturer Market Share in 2019
3.3.2 Top 6 Seasickness Medicine Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Seasickness Medicine Sales, Revenue and Market Share by Regions
4.1.1 Global Seasickness Medicine Sales and Market Share by Regions (2015-2020)
4.1.2 Global Seasickness Medicine Revenue and Market Share by Regions (2015-2020)
4.2 North America Seasickness Medicine Sales and Growth Rate (2015-2020)
4.3 Europe Seasickness Medicine Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Seasickness Medicine Sales and Growth Rate (2015-2020)
4.5 South America Seasickness Medicine Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Seasickness Medicine Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Seasickness Medicine Sales, Revenue and Market Share by Country
5.1.1 North America Seasickness Medicine Sales and Market Share by Country (2015-2020)
5.1.2 North America Seasickness Medicine Revenue and Market Share by Country (2015-2020)
5.2 United States Seasickness Medicine Sales and Growth Rate (2015-2020)
5.3 Canada Seasickness Medicine Sales and Growth Rate (2015-2020)
5.4 Mexico Seasickness Medicine Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Seasickness Medicine Sales, Revenue and Market Share by Country
6.1.1 Europe Seasickness Medicine Sales and Market Share by Country (2015-2020)
6.1.2 Europe Seasickness Medicine Revenue and Market Share by Country (2015-2020)
6.2 Germany Seasickness Medicine Sales and Growth Rate (2015-2020)
6.3 UK Seasickness Medicine Sales and Growth Rate (2015-2020)
6.4 France Seasickness Medicine Sales and Growth Rate (2015-2020)
6.5 Russia Seasickness Medicine Sales and Growth Rate (2015-2020)
6.6 Italy Seasickness Medicine Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Seasickness Medicine Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Seasickness Medicine Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Seasickness Medicine Revenue and Market Share by Regions (2015-2020)
7.2 China Seasickness Medicine Sales and Growth Rate (2015-2020)
7.3 Japan Seasickness Medicine Sales and Growth Rate (2015-2020)
7.4 Korea Seasickness Medicine Sales and Growth Rate (2015-2020)
7.5 India Seasickness Medicine Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Seasickness Medicine Sales and Growth Rate (2015-2020)
7.7 Australia Seasickness Medicine Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Seasickness Medicine Sales, Revenue and Market Share by Country
8.1.1 South America Seasickness Medicine Sales and Market Share by Country (2015-2020)
8.1.2 South America Seasickness Medicine Revenue and Market Share by Country (2015-2020)
8.2 Brazil Seasickness Medicine Sales and Growth Rate (2015-2020)
8.3 Argentina Seasickness Medicine Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Seasickness Medicine Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Seasickness Medicine Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Seasickness Medicine Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Seasickness Medicine Sales and Growth Rate (2015-2020)
9.3 Turkey Seasickness Medicine Sales and Growth Rate (2015-2020)
9.4 Egypt Seasickness Medicine Sales and Growth Rate (2015-2020)
9.5 South Africa Seasickness Medicine Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Seasickness Medicine Sales and Market Share by Type (2015-2020)
10.2 Global Seasickness Medicine Revenue and Market Share by Type (2015-2020)
10.3 Global Seasickness Medicine Price by Type (2015-2020)
11 Global Seasickness Medicine Market Segment by Application
11.1 Global Seasickness Medicine Sales Market Share by Application (2015-2020)
11.2 Global Seasickness Medicine Revenue Market Share by Application (2015-2020)
11.3 Global Seasickness Medicine Price by Application (2015-2020)
12 Market Forecast
12.1 Global Seasickness Medicine Sales, Revenue and Growth Rate (2021-2025)
12.2 Seasickness Medicine Market Forecast by Regions (2021-2025)
12.2.1 North America Seasickness Medicine Market Forecast (2021-2025)
12.2.2 Europe Seasickness Medicine Market Forecast (2021-2025)
12.2.3 Asia-Pacific Seasickness Medicine Market Forecast (2021-2025)
12.2.4 South America Seasickness Medicine Market Forecast (2021-2025)
12.2.5 Middle East & Africa Seasickness Medicine Market Forecast (2021-2025)
12.3 Seasickness Medicine Market Forecast by Type (2021-2025)
12.3.1 Global Seasickness Medicine Sales Forecast by Type (2021-2025)
12.3.2 Global Seasickness Medicine Market Share Forecast by Type (2021-2025)
12.4 Seasickness Medicine Market Forecast by Application (2021-2025)
12.4.1 Global Seasickness Medicine Sales Forecast by Application (2021-2025)
12.4.2 Global Seasickness Medicine Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

List of Tables
Table 1. Global Seasickness Medicine Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Seasickness Medicine by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Seasickness Medicine Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Seasickness Medicine Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 9. GlaxoSmithKline Seasickness Medicine Major Business
Table 10. GlaxoSmithKline Seasickness Medicine Total Revenue (USD Million) (2018-2019)
Table 11. GlaxoSmithKline SWOT Analysis
Table 12. GlaxoSmithKline Seasickness Medicine Product and Services
Table 13. GlaxoSmithKline Seasickness Medicine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. Myungmoon Pharm Basic Information, Manufacturing Base and Competitors
Table 15. Myungmoon Pharm Seasickness Medicine Major Business
Table 16. Myungmoon Pharm Seasickness Medicine Total Revenue (USD Million) (2018-2019)
Table 17. Myungmoon Pharm SWOT Analysis
Table 18. Myungmoon Pharm Seasickness Medicine Product and Services
Table 19. Myungmoon Pharm Seasickness Medicine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. Baxter International Basic Information, Manufacturing Base and Competitors
Table 21. Baxter International Seasickness Medicine Major Business
Table 22. Baxter International Seasickness Medicine Total Revenue (USD Million) (2018-2019)
Table 23. Baxter International SWOT Analysis
Table 24. Baxter International Seasickness Medicine Product and Services
Table 25. Baxter International Seasickness Medicine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. Prestige Brands Basic Information, Manufacturing Base and Competitors
Table 27. Prestige Brands Seasickness Medicine Major Business
Table 28. Prestige Brands Seasickness Medicine Total Revenue (USD Million) (2018-2019)
Table 29. Prestige Brands SWOT Analysis
Table 30. Prestige Brands Seasickness Medicine Product and Services
Table 31. Prestige Brands Seasickness Medicine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. Pfizer Basic Information, Manufacturing Base and Competitors
Table 33. Pfizer Seasickness Medicine Major Business
Table 34. Pfizer Seasickness Medicine Total Revenue (USD Million) (2018-2019)
Table 35. Pfizer SWOT Analysis
Table 36. Pfizer Seasickness Medicine Product and Services
Table 37. Pfizer Seasickness Medicine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. WellSpring Pharmaceutical Corporation Basic Information, Manufacturing Base and Competitors
Table 39. WellSpring Pharmaceutical Corporation Seasickness Medicine Major Business
Table 40. WellSpring Pharmaceutical Corporation Seasickness Medicine Total Revenue (USD Million) (2018-2019)
Table 41. WellSpring Pharmaceutical Corporation SWOT Analysis
Table 42. WellSpring Pharmaceutical Corporation Seasickness Medicine Product and Services
Table 43. WellSpring Pharmaceutical Corporation Seasickness Medicine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 44. Sandoz Basic Information, Manufacturing Base and Competitors
Table 45. Sandoz Seasickness Medicine Major Business
Table 46. Sandoz Seasickness Medicine Total Revenue (USD Million) (2018-2019)
Table 47. Sandoz SWOT Analysis
Table 48. Sandoz Seasickness Medicine Product and Services
Table 49. Sandoz Seasickness Medicine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 50. Mylan Basic Information, Manufacturing Base and Competitors
Table 51. Mylan Seasickness Medicine Major Business
Table 52. Mylan Seasickness Medicine Total Revenue (USD Million) (2018-2019)
Table 53. Mylan SWOT Analysis
Table 54. Mylan Seasickness Medicine Product and Services
Table 55. Mylan Seasickness Medicine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 56. Caleb Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 57. Caleb Pharmaceuticals Seasickness Medicine Major Business
Table 58. Caleb Pharmaceuticals Seasickness Medicine Total Revenue (USD Million) (2018-2019)
Table 59. Caleb Pharmaceuticals SWOT Analysis
Table 60. Caleb Pharmaceuticals Seasickness Medicine Product and Services
Table 61. Caleb Pharmaceuticals Seasickness Medicine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 62. Global Seasickness Medicine Sales by Manufacturer (2018-2019) (K Units)
Table 63. Global Seasickness Medicine Revenue by Manufacturer (2018-2019) (USD Million)
Table 64. Global Seasickness Medicine Sales by Regions (2015-2020) (K Units)
Table 65. Global Seasickness Medicine Sales Market Share by Regions (2015-2020)
Table 66. Global Seasickness Medicine Revenue by Regions (2015-2020) (USD Million)
Table 67. North America Seasickness Medicine Sales by Countries (2015-2020) (K Units)
Table 68. North America Seasickness Medicine Sales Market Share by Countries (2015-2020)
Table 69. North America Seasickness Medicine Revenue by Countries (2015-2020) (USD Million)
Table 70. North America Seasickness Medicine Revenue Market Share by Countries (2015-2020)
Table 71. Europe Seasickness Medicine Sales by Countries (2015-2020) (K Units)
Table 72. Europe Seasickness Medicine Sales Market Share by Countries (2015-2020)
Table 73. Europe Seasickness Medicine Revenue by Countries (2015-2020) (USD Million)
Table 74. Asia-Pacific Seasickness Medicine Sales by Regions (2015-2020) (K Units)
Table 75. Asia-Pacific Seasickness Medicine Sales Market Share by Regions (2015-2020)
Table 76. Asia-Pacific Seasickness Medicine Revenue by Regions (2015-2020) (USD Million)
Table 77. South America Seasickness Medicine Sales by Countries (2015-2020) (K Units)
Table 78. South America Seasickness Medicine Sales Market Share by Countries (2015-2020)
Table 79. South America Seasickness Medicine Revenue by Countries (2015-2020) (USD Million)
Table 80. South America Seasickness Medicine Revenue Market Share by Countries (2015-2020)
Table 81. Middle East & Africa Seasickness Medicine Sales by Countries (2015-2020) (K Units)
Table 82. Middle East & Africa Seasickness Medicine Sales Market Share by Countries (2015-2020)
Table 83. Middle East & Africa Seasickness Medicine Revenue by Countries (2015-2020) (USD Million)
Table 84. Middle East & Africa Seasickness Medicine Revenue Market Share by Countries (2015-2020)
Table 85. Global Seasickness Medicine Sales by Type (2015-2020) (K Units)
Table 86. Global Seasickness Medicine Sales Share by Type (2015-2020)
Table 87. Global Seasickness Medicine Revenue by Type (2015-2020) (USD Million)
Table 88. Global Seasickness Medicine Revenue Share by Type (2015-2020)
Table 89. Global Seasickness Medicine Sales by Application (2015-2020) (K Units)
Table 90. Global Seasickness Medicine Sales Share by Application (2015-2020)
Table 91. Global Seasickness Medicine Sales Forecast by Regions (2021-2025) (K Units)
Table 92. Global Seasickness Medicine Market Share Forecast by Regions (2021-2025)
Table 93. Global Seasickness Medicine Sales Forecast by Type (2021-2025) (K Units)
Table 94. Global Seasickness Medicine Market Share Forecast by Type (2021-2025)
Table 95. Global Seasickness Medicine Sales Forecast by Application (2021-2025)
Table 96. Global Seasickness Medicine Market Share Forecast by Application (2021-2025)
Table 97. Direct Channel Pros & Cons
Table 98. Indirect Channel Pros & Cons
Table 99. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Seasickness Medicine Picture
Figure 2. Global Sales Market Share of Seasickness Medicine by Type in 2019
Figure 3. Anticholinergic Picture
Figure 4. Antihistamines Picture
Figure 5. Others Picture
Figure 6. Seasickness Medicine Sales Market Share by Application in 2018
Figure 7. Adults Picture
Figure 8. Children Picture
Figure 9. Global Seasickness Medicine Market Status and Outlook (2015-2025) (USD Million)
Figure 10. United States Seasickness Medicine Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Canada Seasickness Medicine Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Mexico Seasickness Medicine Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Germany Seasickness Medicine Revenue (Value) and Growth Rate (2015-2025)
Figure 14. France Seasickness Medicine Revenue (Value) and Growth Rate (2015-2025)
Figure 15. UK Seasickness Medicine Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Russia Seasickness Medicine Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Italy Seasickness Medicine Revenue (Value) and Growth Rate (2015-2025)
Figure 18. China Seasickness Medicine Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Japan Seasickness Medicine Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Korea Seasickness Medicine Revenue (Value) and Growth Rate (2015-2025)
Figure 21. India Seasickness Medicine Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Southeast Asia Seasickness Medicine Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Australia Seasickness Medicine Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 24. Brazil Seasickness Medicine Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Egypt Seasickness Medicine Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Saudi Arabia Seasickness Medicine Revenue (Value) and Growth Rate (2015-2025)
Figure 27. South Africa Seasickness Medicine Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Turkey Seasickness Medicine Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Global Seasickness Medicine Sales Market Share by Manufacturer in 2019
Figure 30. Global Seasickness Medicine Revenue Market Share by Manufacturer in 2019
Figure 31. Top 3 Seasickness Medicine Manufacturer (Revenue) Market Share in 2019
Figure 32. Top 6 Seasickness Medicine Manufacturer (Revenue) Market Share in 2019
Figure 33. Key Manufacturer Market Share Trend
Figure 34. Global Seasickness Medicine Sales and Growth Rate (2015-2020) (K Units)
Figure 35. Global Seasickness Medicine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 36. Global Seasickness Medicine Revenue Market Share by Regions (2015-2020)
Figure 37. Global Seasickness Medicine Revenue Market Share by Regions in 2018
Figure 38. North America Seasickness Medicine Sales and Growth Rate (2015-2020)
Figure 39. Europe Seasickness Medicine Sales and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Seasickness Medicine Sales and Growth Rate (2015-2020)
Figure 41. South America Seasickness Medicine Sales and Growth Rate (2015-2020)
Figure 42. Middle East & Africa Seasickness Medicine Sales and Growth Rate (2015-2020)
Figure 43. North America Seasickness Medicine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 44. North America Seasickness Medicine Sales Market Share by Countries (2015-2020)
Figure 45. North America Seasickness Medicine Sales Market Share by Countries in 2018
Figure 46. North America Seasickness Medicine Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 47. North America Seasickness Medicine Revenue Market Share by Countries in 2018
Figure 48. United States Seasickness Medicine Sales and Growth Rate (2015-2020) (K Units)
Figure 49. Canada Seasickness Medicine Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Mexico Seasickness Medicine Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Europe Seasickness Medicine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 52. Europe Seasickness Medicine Revenue Market Share by Countries (2015-2020)
Figure 53. Europe Seasickness Medicine Revenue Market Share by Countries in 2019
Figure 54. Germany Seasickness Medicine Sales and Growth Rate (2015-2020) (K Units)
Figure 55. UK Seasickness Medicine Sales and Growth Rate (2015-2020) (K Units)
Figure 56. France Seasickness Medicine Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Russia Seasickness Medicine Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Italy Seasickness Medicine Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Asia-Pacific Seasickness Medicine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 60. Asia-Pacific Seasickness Medicine Sales Market Share by Regions 2019
Figure 61. Asia-Pacific Seasickness Medicine Revenue Market Share by Regions 2019
Figure 62. China Seasickness Medicine Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Japan Seasickness Medicine Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Korea Seasickness Medicine Sales and Growth Rate (2015-2020) (K Units)
Figure 65. India Seasickness Medicine Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Southeast Asia Seasickness Medicine Sales and Growth Rate (2015-2020) (K Units)
Figure 67. South America Seasickness Medicine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 68. South America Seasickness Medicine Sales Market Share by Countries in 2019
Figure 69. South America Seasickness Medicine Revenue Market Share by Countries in 2019
Figure 70. Brazil Seasickness Medicine Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Argentina Seasickness Medicine Sales and Growth Rate (2015-2020) (K Units)
Figure 72. Middle East and Africa Seasickness Medicine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. Middle East and Africa Seasickness Medicine Sales Market Share by Countries in 2019
Figure 74. Middle East and Africa Seasickness Medicine Revenue Market Share by Countries (2015-2020)
Figure 75. Middle East and Africa Seasickness Medicine Revenue Market Share by Countries in 2019
Figure 76. Saudi Arabia Seasickness Medicine Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Egypt Seasickness Medicine Sales and Growth Rate (2015-2020) (K Units)
Figure 78. Turkey Seasickness Medicine Sales and Growth Rate (2015-2020) (K Units)
Figure 79. South Africa Seasickness Medicine Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Global Seasickness Medicine Sales and Growth Rate (2021-2025) (K Units)
Figure 81. Global Seasickness Medicine Revenue and Growth Rate (2021-2025) (USD Million)
Figure 82. North America Sales Seasickness Medicine Market Forecast (2021-2025) (K Units)
Figure 83. Europe Sales Seasickness Medicine Market Forecast (2021-2025) (K Units)
Figure 84. Asia-Pacific Sales Seasickness Medicine Market Forecast (2021-2025) (K Units)
Figure 85. South America Sales Seasickness Medicine Market Forecast (2021-2025) (K Units)
Figure 86. Middle East & Africa Sales Seasickness Medicine Market Forecast (2021-2025) (K Units)
Figure 87. Sales Channel: Direct Channel vs Indirect Channel